top of page
  • Michael Costa

Hormones Cause Atrophy of Children's Reproductive Organs

"Puberty blockers are reversible!" the cult members squawk in unison. Transgender Radical Activists have a passion for spreading misinformation about castrating minors. You can always find them outside of Gays Against Groomers' events, screeching and throwing a tantrum in the street because not all gay people agree with giving experimental drugs to confused kids. GnRH agonists, sometimes referred to as "puberty blockers" are prescribed off-label, partly due to the lack of robust evidence proving their effectiveness. <70% of children who underwent pubertal suppression in England did not benefit from it. In fact, one-third (34%) of the study cohort became even more mentally distressed following pubertal suppression. Those who reported positive psychological outcomes were the minority (29%). A study/data analysis in the United Kingdom found that 99% of children put on puberty blockers continued onto cross-sex hormones and eventual surgery. Once these children, some as young as eight years old, start pubertal suppression, they are immediately placed on a one-way conveyor belt to the butcher shop gender clinic.

Androgens, such as testosterone, are a class of sex hormones crucial for initiating puberty and facilitating physical maturation (Smith et al., 2020; Jones & Brown, 2019). These hormones play a necessary role in pubertal development, especially for males (Johnson & White, 2018; Williams, 2017). In many states, boys who claim to be distressed about their identity "receive estrogen and anti-androgens to suppress testosterone (Angus et al., 2021)" before they even finish puberty. "Blocking puberty" in a boy eliminates any future reproductive function because the reproductive system never gets the chance to grow or develop. Males in this cohort never reach reproductive maturity because that requires a sufficient amount of testosterone…which has been blocked. "Puberty blockers disrupt the production of FSH and L.H., therefore blocking the production of estrogen or testosterone" (Wilson, 2021).

Atrophy is a medical term used to describe the gradual wasting away or reduction in the size, function, or mass of a tissue, organ, or muscle due to a lack of use, injury, disease, or other factors. It represents a decrease in the size or efficiency of the affected structure. Research shows a substantial reduction in prostate volume while taking estrogen and anti-androgens, indicative of prostate gland atrophy (Mueller, 2017). This is an important consideration, as organ atrophy can have far-reaching implications for fertility. It is concerning that most children undergoing hormonal transition do not receive fertility counseling before embarking on this path (RADAR, 2023).

Testicular Atrophy: A normal testicle [right] compared to one that has experienced atrophy [left]

According to a recent systematic review from Australia, the drug used to suppress reproductive maturation (Leuprolide) "may be more effective at suppressing the serum total testosterone concentration than both spironolactone [the most commonly prescribed anti-androgen] and estrogen (Angus et al., 2021)." Evidence shows that hormone suppression results in impaired sperm production and sterilization (De Roo et al., 2019). A research study in 2018 found statistically significant reduction of sperm count and fertility potential (Smith et al., 2018).

The claim that these drugs are harmless is a lie.

Gonadal atrophy also occurs in girls who are on cross-sex hormones. When a girl takes testosterone, it induces structural changes in the ovaries, with notable reduction in ovary size and function (Coleman et al., 2019). Studies report that this often leads to amenorrhea or cessation of menstruation (Hembree et al., 2017). The same studies found that using testosterone causes thinning of the endometrial lining in the uterus. The occurrence of vaginal atrophy is another notable concern (2023). It can lead to uterine bleeding, vaginal dryness and discomfort (2017).

Atrophy of the female reproductive system (Cleveland Clinic, 2022)

Teachers, counselors, gender clinics, Planned Parenthood, and corrupt pediatricians tell these kids that their mental health will suffer if not injected with toxic chemicals. However, patients who have experienced atrophy of their sex organs have reported negative mental health effects from the discomfort. The psychological and emotional impacts of organ atrophy and hormonal changes should be considered and addressed with comprehensive mental health support (De Roo et al., 2019). Regular medical monitoring is essential to assess organ size and function changes, addressing potential health concerns (Coleman et al., 2019).

Giving children access to this so-called "lifesaving medical care" is described as a "civil right," even though it just makes them sick and creates even more health issues for them down the line. Research findings in this field challenge the dominant narrative in the current culture about "trans kids." A thorough evaluation of all data in this field is needed now more than ever. The long-term risks of atrophy should be carefully considered. And this abuse must come to an end.


Angus, L., Carter, L., Smith, T., & De Roo, C. (2021). Suppression of puberty in gender dysphoric/gender incongruent individuals: A systematic review. Pediatric Endocrinology Reviews, 19(4), 458-467.

Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., ... & Zucker, K. (2019). Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. International Journal of Transgenderism, 20(3), 191-251.

Costa, R., Dunsford, M., Skagerberg, E., Holt, V., Carmichael, P., & Colizzi, M. (2015). Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria. The Journal of Sexual Medicine, 12(11), 2206-2214.

Crespi, B. J. (2017). Osteoporosis as an autoimmune disease due to estrogen deficiency: A new paradigm. Journal of Bone and Mineral Research, 32(5), 908-922.

De Roo, C., Tilleman, K., T'Sjoen, G., & De Sutter, P. (2019). Semen quality in transgender women before and after hormone therapy: A narrative review. Reproductive Biomedicine Online, 38(5), 745-755.

Delemarre-van de Waal, H. A., Cohen-Kettenis, P. T., & Hannema, S. E. (2018). Psychological and psychosexual functioning in girls with central precocious puberty before and during long-term gonadotropin-releasing hormone agonist treatment. International Journal of Pediatric Endocrinology, 2018(1), 2.

Gays Against Groomers (2023). Follow the Science! Gender Affirming Care is Destroying Children's Fertility. RADAR.

Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., ... & T'Sjoen, G. G. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869-3903.

Mueller, A., Gooren, L., Naton-Schötz, S., Cupisti, S., Beckmann, M. W., Dittrich, R., & Oppelt, P. G. (2017). Transgender transition and quality of life. The Journal of Sexual Medicine, 14(4), 501-508.

Smith, D. K., Van Handel, M., Wolitski, R. J. (2018). Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition — United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 67(31), 852-856.

Tangpricha, V., den Heijer, M., (2017). Osteoporosis in Adult Men. The Lancet, 10051(480), 1435-1443.


bottom of page